Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F-L Cosset

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Cancer Gene Therapy|November 7, 2009
Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancerE-H Lin, C Salon, E Brambilla, et al.
Nature Biotechnology|October 27, 1998
In vivo selection of protease cleavage sites from retrovirus display librariesC J Buchholz, K W Peng, F J Morling, et al.
Human Gene Therapy|November 10, 1996
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivityS Ager, B H Nilson, F J Morling, et al.
Gene Therapy|October 11, 2001
Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectorsK W Peng, L Pham, H Ye, et al.
Journal of Virology|March 1, 1996
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SUS Valsesia-Wittmann, F J Morling, B H Nilson, et al.
Gene Therapy|March 8, 2008
Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesisC Frecha, M G Toscano, C Costa, et al.
Human Gene Therapy|April 25, 2000
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand displayA K Fielding, S Chapel-Fernandes, M P Chadwick, et al.
Blood|July 9, 1999
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteinsM Maurice, S Mazur, F J Bullough, et al.
Journal of Virology|May 1, 1996
Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteinsM Marin, D Noël, S Valsesia-Wittman, et al.
Journal of Virology|July 1, 1994
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectorsS Valsesia-Wittmann, A Drynda, G Deléage, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cancer Gene Therapy|November 7, 2009
Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancerE-H Lin, C Salon, E Brambilla, et al.
Nature Biotechnology|October 27, 1998
In vivo selection of protease cleavage sites from retrovirus display librariesC J Buchholz, K W Peng, F J Morling, et al.
Human Gene Therapy|November 10, 1996
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivityS Ager, B H Nilson, F J Morling, et al.
Gene Therapy|October 11, 2001
Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectorsK W Peng, L Pham, H Ye, et al.
Journal of Virology|March 1, 1996
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SUS Valsesia-Wittmann, F J Morling, B H Nilson, et al.
Gene Therapy|March 8, 2008
Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesisC Frecha, M G Toscano, C Costa, et al.
Human Gene Therapy|April 25, 2000
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand displayA K Fielding, S Chapel-Fernandes, M P Chadwick, et al.
Blood|July 9, 1999
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteinsM Maurice, S Mazur, F J Bullough, et al.
Journal of Virology|May 1, 1996
Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteinsM Marin, D Noël, S Valsesia-Wittman, et al.
Journal of Virology|July 1, 1994
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectorsS Valsesia-Wittmann, A Drynda, G Deléage, et al.
Pageof 9